These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22349104)

  • 81. Augmentation therapy in alpha(1)-antitrypsin deficiency.
    Burdon JG; Brenton S; Ayad M; Knight K
    Chest; 2001 Aug; 120(2):687. PubMed ID: 11502686
    [No Abstract]   [Full Text] [Related]  

  • 82. Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus.
    Park SS; Rodriguez Ortega R; Agudelo CW; Perez Perez J; Perez Gandara B; Garcia-Arcos I; McCarthy C; Geraghty P
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33923873
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Treatment for Alpha-1 Antitrypsin Deficiency: Does Augmentation Therapy Work?
    Brantly M
    Am J Respir Crit Care Med; 2023 Nov; 208(9):948-949. PubMed ID: 37724887
    [No Abstract]   [Full Text] [Related]  

  • 84. [Hereditary deficiency of alpha 1- antitrypsin in rats due to evolving chronic lung pathology].
    Soloveva NA; Grishaeva ON; Parik IuIa; Kosova EIu; Korolenko TA
    Vestn Ross Akad Med Nauk; 1994; (2):31-4. PubMed ID: 7513577
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [French clinical practice guidelines for the diagnosis and management of lung disease with alpha 1-antitrypsin deficiency].
    Mornex JF; Balduyck M; Bouchecareilh M; Cuvelier A; Epaud R; Kerjouan M; Le Rouzic O; Pison C; Plantier L; Pujazon MC; Reynaud-Gaubert M; Toutain A; Trumbic B; Willemin MC; Zysman M; Brun O; Campana M; Chabot F; Chamouard V; Dechomet M; Fauve J; Girerd B; Gnakamene C; Lefrançois S; Lombard JN; Maitre B; Maynié-François C; Moerman A; Payancé A; Reix P; Revel D; Revel MP; Schuers M; Terrioux P; Theron D; Willersinn F; Cottin V; Mal H
    Rev Mal Respir; 2022 Sep; 39(7):633-656. PubMed ID: 35906149
    [No Abstract]   [Full Text] [Related]  

  • 86. Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. American Thoracic Society.
    Am Rev Respir Dis; 1989 Nov; 140(5):1494-7. PubMed ID: 2683912
    [No Abstract]   [Full Text] [Related]  

  • 87. [RAPID study: the first time the value of substitution therapy is verified].
    MMW Fortschr Med; 2016 Jun; 158(12):68-9. PubMed ID: 27462663
    [No Abstract]   [Full Text] [Related]  

  • 88. Revisiting alpha1-antitrypsin therapy in cystic fibrosis: can it still offer promise?
    Brennan S
    Eur Respir J; 2007 Feb; 29(2):229-30. PubMed ID: 17264320
    [No Abstract]   [Full Text] [Related]  

  • 89. The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders.
    Breit SN; Wakefield D; Robinson JP; Luckhurst E; Clark P; Penny R
    Clin Immunol Immunopathol; 1985 Jun; 35(3):363-80. PubMed ID: 3886224
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [In process].
    Ameri AA
    Med Monatsschr Pharm; 2017 Jan; 40(1):38-9. PubMed ID: 29952536
    [No Abstract]   [Full Text] [Related]  

  • 91. Reflections from the field regarding the clinical commentary for augmentation therapy in the MZ phenotype.
    Reddy SP; Zaremba M
    Chest; 2009 Apr; 135(4):1109-1110. PubMed ID: 19349412
    [No Abstract]   [Full Text] [Related]  

  • 92. [With comprehensive therapy system early diagnosis and treatment].
    Girrbach G
    MMW Fortschr Med; 2016 May; 158(9):67. PubMed ID: 27155717
    [No Abstract]   [Full Text] [Related]  

  • 93. The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.
    Janciauskiene S; Wrenger S; Immenschuh S; Olejnicka B; Greulich T; Welte T; Chorostowska-Wynimko J
    Front Pharmacol; 2018; 9():341. PubMed ID: 29719508
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The multiple facets of alpha-1-antitrypsin.
    Stockley RA
    Ann Transl Med; 2015 Jun; 3(10):130. PubMed ID: 26207223
    [TBL] [Abstract][Full Text] [Related]  

  • 95. α-1 antitrypsin and chronic fatigue syndrome: a case study from pathophysiology to clinical practice.
    Alegre J; Camprubí S; García-Quintana A
    Pain Manag; 2013 Mar; 3(2):119-22. PubMed ID: 24645995
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparison of the liquid and lyophilized formulations of Prolastin®-C for Alpha
    Arora V; Cruz M; Lang J; Klos AM; Merritt WK; Price J; Taylor G; Vandeberg P; Wee K; Willis T
    Biologicals; 2019 Nov; 62():77-84. PubMed ID: 31522909
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Alpha-1-antitrypsin safely promotes rapid recovery of pigs after lung transplantation.
    Mariscal A; Tikkanen J; Calderone L; Hough O; Chen M; Martinu T; Juvet S; Cypel M; Liu M; Keshavjee S
    Am J Transplant; 2023 Jul; 23(7):1082-1084. PubMed ID: 37004914
    [No Abstract]   [Full Text] [Related]  

  • 98. The pharmacology and toxicology of three new biologic agents used in pulmonary medicine.
    Albertson TE; Walby WF; Allen RP; Tharratt RS
    J Toxicol Clin Toxicol; 1995; 33(5):427-38. PubMed ID: 7650767
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Recent advances in experimental and clinical study on ligustrazine in treating respiratory disease].
    Zhang KJ; Zhang YX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):638-40. PubMed ID: 8704434
    [No Abstract]   [Full Text] [Related]  

  • 100. Inhaled alpha1-antitrypsin administered to treat pneumatocele in autosomal dominant hyperimmunoglobulin E syndrome.
    Karakoc-Aydiner E; Baris S; Keles S; Ozdemir C; Chatila T; Barlan I
    J Investig Allergol Clin Immunol; 2013; 23(5):359-61. PubMed ID: 24260982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.